To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Friday Letter Candian envy
The proposed $5.2bn IMS Health buyout is interesting for more than its size – it looks like the kind of deal that most large LPs wish they could do.
